Related Experiment Video

Updated: Jun 8, 2025

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

2.5K

Immune Cell-Derived Exosomes: A Cell-Free Cutting-Edge Tumor Immunotherapy

Ranjini Sengupta1, Ibrahim S Topiwala1, Meghana Shakthi A1

  • 1Cancer and Stem Cell Biology Laboratory, Department of Genetic Engineering, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu District, TamilNadu 603203, India.

ACS Applied Bio Materials
|November 4, 2024
PubMed

Insights

Immune cell-derived exosomes offer a promising, less toxic cell-free immunotherapy for cancer treatment. These extracellular vesicles show potential for targeted cancer therapy and biomarker discovery.

Area of Science:

  • Biomedical research
  • Cancer biology
  • Immunology

Background:

  • Extracellular vesicles (EVs) are key intercellular communicators, with exosomes being crucial in cancer research.
  • Tumor-derived exosomes can drive cancer progression and serve as biomarkers in bodily fluids.
  • Current cancer immunotherapies face limitations like toxicity and high costs.

Purpose of the Study:

  • To review the therapeutic potential of immune cell-derived exosomes in cancer treatment.
  • To highlight exosomes as a cell-free immunotherapy alternative.
  • To discuss the advantages of immune cell-derived exosomes over traditional immunotherapies.

Main Methods:

  • Literature review of exosomes in cancer research.
  • Analysis of exosome classification and function.
  • Evaluation of therapeutic applications of immune cell-derived exosomes.

Main Results:

  • Exosomes are vital in cancer progression and diagnosis.
  • Immune cell-derived exosomes demonstrate significant cancer-healing properties.
  • Exosome-based immunotherapy offers advantages such as reduced toxicity and improved biocompatibility.

Conclusions:

  • Immune cell-derived exosomes represent a promising cell-free therapeutic strategy for cancer.
  • Their targeted delivery and reduced immunogenicity make them advantageous for cancer treatment.
  • Further research into exosome-based therapies could revolutionize cancer care.
Keywords:
CancerExosomesExtracellular vesiclesImmunotherapyMetastasis

More Related Videos

Preparation of Exosomes for siRNA Delivery to Cancer Cells09:59

Preparation of Exosomes for siRNA Delivery to Cancer Cells

Published on: December 5, 2018

24.9K
A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells11:15

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

10.2K

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
484
Overview of Exosomes01:36

Overview of Exosomes

Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K